TEAM
Jordi Martorell
CEO and Co-Founder
PhD in Chemical Engineering and specialized in Biomedical Engineering. Dr Martorell oversees all activities, including scientific oversight, finance control, business design and regulatory design. At IQS, he is the Head of Vascular Engineering and Applied Biomedicine. Jordi has been focused on vascular biology for more than ten years at MIT and IQS. He has extensive experience collaborating with medical device companies to improve the design of coronary stents and arterial valves.
PhD in Chemical Engineering and specialized in Biomedical Engineering. Dr Martorell oversees all activities, including scientific oversight, finance control, business design and regulatory design. At IQS, he is the Head of Vascular Engineering and Applied Biomedicine. Jordi has been focused on vascular biology for more than ten years at MIT and IQS. He has extensive experience collaborating with medical device companies to improve the design of coronary stents and arterial valves.
PhD in Chemical Engineering and specialized in Biomedical Engineering. Dr Martorell oversees all activities, including scientific oversight, finance control, business design and regulatory design. At IQS, he is the Head of Vascular Engineering and Applied Biomedicine. Jordi has been focused on vascular biology for more than ten years at MIT and IQS. He has extensive experience collaborating with medical device companies to improve the design of coronary stents and arterial valves.
PhD in Chemical Engineering and specialized in Biomedical Engineering. Dr Martorell oversees all activities, including scientific oversight, finance control, business design and regulatory design. At IQS, he is the Head of Vascular Engineering and Applied Biomedicine. Jordi has been focused on vascular biology for more than ten years at MIT and IQS. He has extensive experience collaborating with medical device companies to improve the design of coronary stents and arterial valves.
PhD in Chemical Engineering and specialized in Biomedical Engineering. Dr Martorell oversees all activities, including scientific oversight, finance control, business design and regulatory design. At IQS, he is the Head of Vascular Engineering and Applied Biomedicine. Jordi has been focused on vascular biology for more than ten years at MIT and IQS. He has extensive experience collaborating with medical device companies to improve the design of coronary stents and arterial valves.
Noemí Balà
CTO and Co-Founder
PhD in Chemical Engineering. Noemí oversees all product-development related activities, including R&D, prototyping, and pre-clinical experimentation. She has more than 5 years’ experience in biomaterials for medical devices at MIT and IQS. Noemí has been working on this project since 2016.
PhD in Chemical Engineering. Noemí oversees all product-development related activities, including R&D, prototyping, and pre-clinical experimentation. She has more than 5 years’ experience in biomaterials for medical devices at MIT and IQS. Noemí has been working on this project since 2016.
PhD in Chemical Engineering. Noemí oversees all product-development related activities, including R&D, prototyping, and pre-clinical experimentation. She has more than 5 years’ experience in biomaterials for medical devices at MIT and IQS. Noemí has been working on this project since 2016.
PhD in Chemical Engineering. Noemí oversees all product-development related activities, including R&D, prototyping, and pre-clinical experimentation. She has more than 5 years’ experience in biomaterials for medical devices at MIT and IQS. Noemí has been working on this project since 2016.
PhD in Chemical Engineering. Noemí oversees all product-development related activities, including R&D, prototyping, and pre-clinical experimentation. She has more than 5 years’ experience in biomaterials for medical devices at MIT and IQS. Noemí has been working on this project since 2016.
Salvador Borrós
CSO and Co-Founder
PhD in Analytical Chemistry Materials. Dr Borrós oversees all scientific activities. At IQS, he is the Director and Head of the Materials Engineering Group (GEMAT). Dr. Borrós is Professor of Material Sciences since 1994. His portfolio of human applications includes tissue regeneration, nanoparticles and synthetic vectors for drug and gene delivery.
PhD in Analytical Chemistry Materials. Dr Borrós oversees all scientific activities. At IQS, he is the Director and Head of the Materials Engineering Group (GEMAT). Dr. Borrós is Professor of Material Sciences since 1994. His portfolio of human applications includes tissue regeneration, nanoparticles and synthetic vectors for drug and gene delivery.
PhD in Analytical Chemistry Materials. Dr Borrós oversees all scientific activities. At IQS, he is the Director and Head of the Materials Engineering Group (GEMAT). Dr. Borrós is Professor of Material Sciences since 1994. His portfolio of human applications includes tissue regeneration, nanoparticles and synthetic vectors for drug and gene delivery.
PhD in Analytical Chemistry Materials. Dr Borrós oversees all scientific activities. At IQS, he is the Director and Head of the Materials Engineering Group (GEMAT). Dr. Borrós is Professor of Material Sciences since 1994. His portfolio of human applications includes tissue regeneration, nanoparticles and synthetic vectors for drug and gene delivery.
PhD in Analytical Chemistry Materials. Dr Borrós oversees all scientific activities. At IQS, he is the Director and Head of the Materials Engineering Group (GEMAT). Dr. Borrós is Professor of Material Sciences since 1994. His portfolio of human applications includes tissue regeneration, nanoparticles and synthetic vectors for drug and gene delivery.
Vicenç Riambau
Medical Liaison and Co-Founder
MD and PhD in Medicine. Vicenç is the Chief of Vascular Surgery at Hospital Clínic de Barcelona. Dr. Riambau guides and advices the technical team by providing his extensive medical know-how. He is a specialist and worldwide key opinion leader in Endovascular Surgery. He has been President or Vice-President of the most important international societies for Vascular Surgery. Dr. Riambau is devoted to delivering the best available treatment to our patients by strongly collaborating with the medical device industry. He has been involved in dozens of clinical trials for novel vascular treatments, and consults for almost every vascular device company.
MD and PhD in Medicine. Vicenç is the Chief of Vascular Surgery at Hospital Clínic de Barcelona. Dr. Riambau guides and advices the technical team by providing his extensive medical know-how. He is a specialist and worldwide key opinion leader in Endovascular Surgery. He has been President or Vice-President of the most important international societies for Vascular Surgery. Dr. Riambau is devoted to delivering the best available treatment to our patients by strongly collaborating with the medical device industry. He has been involved in dozens of clinical trials for novel vascular treatments, and consults for almost every vascular device company.
MD and PhD in Medicine. Vicenç is the Chief of Vascular Surgery at Hospital Clínic de Barcelona. Dr. Riambau guides and advices the technical team by providing his extensive medical know-how. He is a specialist and worldwide key opinion leader in Endovascular Surgery. He has been President or Vice-President of the most important international societies for Vascular Surgery. Dr. Riambau is devoted to delivering the best available treatment to our patients by strongly collaborating with the medical device industry. He has been involved in dozens of clinical trials for novel vascular treatments, and consults for almost every vascular device company.
MD and PhD in Medicine. Vicenç is the Chief of Vascular Surgery at Hospital Clínic de Barcelona. Dr. Riambau guides and advices the technical team by providing his extensive medical know-how. He is a specialist and worldwide key opinion leader in Endovascular Surgery. He has been President or Vice-President of the most important international societies for Vascular Surgery. Dr. Riambau is devoted to delivering the best available treatment to our patients by strongly collaborating with the medical device industry. He has been involved in dozens of clinical trials for novel vascular treatments, and consults for almost every vascular device company.
MD and PhD in Medicine. Vicenç is the Chief of Vascular Surgery at Hospital Clínic de Barcelona. Dr. Riambau guides and advices the technical team by providing his extensive medical know-how. He is a specialist and worldwide key opinion leader in Endovascular Surgery. He has been President or Vice-President of the most important international societies for Vascular Surgery. Dr. Riambau is devoted to delivering the best available treatment to our patients by strongly collaborating with the medical device industry. He has been involved in dozens of clinical trials for novel vascular treatments, and consults for almost every vascular device company.
Alex Aranda
R&D
R&D
R&D
PhD Candidate in Bioengineering. Alex has been developing and validating the patch intravascular deployer and the deployment system of the patch. Currently, he works on the design of the handle and a sealing system for the catheter. He has extensive experience in coupling his ideas and knowledge in materials, design and manufacturing with the insights from clinical surgeons and university professors at MIT and IQS.
PhD Candidate in Bioengineering. Alex has been developing and validating the patch intravascular deployer and the deployment system of the patch. Currently, he works on the design of the handle and a sealing system for the catheter. He has extensive experience in coupling his ideas and knowledge in materials, design and manufacturing with the insights from clinical surgeons and university professors at MIT and IQS.
PhD Candidate in Bioengineering. Alex has been developing and validating the patch intravascular deployer and the deployment system of the patch. Currently, he works on the design of the handle and a sealing system for the catheter. He has extensive experience in coupling his ideas and knowledge in materials, design and manufacturing with the insights from clinical surgeons and university professors at MIT and IQS.
PhD Candidate in Bioengineering. Alex has been developing and validating the patch intravascular deployer and the deployment system of the patch. Currently, he works on the design of the handle and a sealing system for the catheter. He has extensive experience in coupling his ideas and knowledge in materials, design and manufacturing with the insights from clinical surgeons and university professors at MIT and IQS.
PhD Candidate in Bioengineering. Alex has been developing and validating the patch intravascular deployer and the deployment system of the patch. Currently, he works on the design of the handle and a sealing system for the catheter. He has extensive experience in coupling his ideas and knowledge in materials, design and manufacturing with the insights from clinical surgeons and university professors at MIT and IQS.
Pau Teixidó
R&D
R&D
R&D
PhD Candidate in Chemistry and Chemical Engineering. Pau designs and executes the ex vivo tests, the degradation and cytotoxicity assays and the adhesive’s formulation and manufacture. He has been working on this project since 2018.
PhD Candidate in Chemistry and Chemical Engineering. Pau designs and executes the ex vivo tests, the degradation and cytotoxicity assays and the adhesive’s formulation and manufacture. He has been working on this project since 2018.
PhD Candidate in Chemistry and Chemical Engineering. Pau designs and executes the ex vivo tests, the degradation and cytotoxicity assays and the adhesive’s formulation and manufacture. He has been working on this project since 2018.
PhD Candidate in Chemistry and Chemical Engineering. Pau designs and executes the ex vivo tests, the degradation and cytotoxicity assays and the adhesive’s formulation and manufacture. He has been working on this project since 2018.
PhD Candidate in Chemistry and Chemical Engineering. Pau designs and executes the ex vivo tests, the degradation and cytotoxicity assays and the adhesive’s formulation and manufacture. He has been working on this project since 2018.
Inés Moreno
R&D
R&D
R&D
PhD Tissue Engineering and Regenerative Medicine. Inés focuses on the combination of the patch with peptides and drugs, to treat aortic aneurysms, and the pre-clinical validation of these models. She has extensive experience working in in vitro and in vivo testing of biomaterials in angiogenesis at University of Southampton, Linköping University and Queensland University of Technology.
PhD Tissue Engineering and Regenerative Medicine. Inés focuses on the combination of the patch with peptides and drugs, to treat aortic aneurysms, and the pre-clinical validation of these models. She has extensive experience working in in vitro and in vivo testing of biomaterials in angiogenesis at University of Southampton, Linköping University and Queensland University of Technology.
PhD Tissue Engineering and Regenerative Medicine. Inés focuses on the combination of the patch with peptides and drugs, to treat aortic aneurysms, and the pre-clinical validation of these models. She has extensive experience working in in vitro and in vivo testing of biomaterials in angiogenesis at University of Southampton, Linköping University and Queensland University of Technology.
PhD Tissue Engineering and Regenerative Medicine. Inés focuses on the combination of the patch with peptides and drugs, to treat aortic aneurysms, and the pre-clinical validation of these models. She has extensive experience working in in vitro and in vivo testing of biomaterials in angiogenesis at University of Southampton, Linköping University and Queensland University of Technology.
PhD Tissue Engineering and Regenerative Medicine. Inés focuses on the combination of the patch with peptides and drugs, to treat aortic aneurysms, and the pre-clinical validation of these models. She has extensive experience working in in vitro and in vivo testing of biomaterials in angiogenesis at University of Southampton, Linköping University and Queensland University of Technology.
Carlota Molhoek
R&D
R&D
R&D
Graduate in Industrial Engineering and MSc in Robotics and Automation. Carlota focuses on the development and validation of the intravascular deployment system of the patch. Besides, she is developing the adhesive application system. She specialized in Bioengineering at Illinois Institute of Technology.
Graduate in Industrial Engineering and MSc in Robotics and Automation. Carlota focuses on the development and validation of the intravascular deployment system of the patch. Besides, she is developing the adhesive application system. She specialized in Bioengineering at Illinois Institute of Technology.
Graduate in Industrial Engineering and MSc in Robotics and Automation. Carlota focuses on the development and validation of the intravascular deployment system of the patch. Besides, she is developing the adhesive application system. She specialized in Bioengineering at Illinois Institute of Technology.
Graduate in Industrial Engineering and MSc in Robotics and Automation. Carlota focuses on the development and validation of the intravascular deployment system of the patch. Besides, she is developing the adhesive application system. She specialized in Bioengineering at Illinois Institute of Technology.
Graduate in Industrial Engineering and MSc in Robotics and Automation. Carlota focuses on the development and validation of the intravascular deployment system of the patch. Besides, she is developing the adhesive application system. She specialized in Bioengineering at Illinois Institute of Technology.
Germán Febas
R&D
R&D
R&D
PhD in Bioengineering specialized on Applied Science in Biomedicine. Germán focuses on the development of the patch, including material design, patch structure and characterization. He has experience in the development of medical devices used in fetal surgery. He masters several manufacturing techniques involving biological tissue, biomaterials, bioadhesives, polymeric coatings and electrospinning.
PhD in Bioengineering specialized on Applied Science in Biomedicine. Germán focuses on the development of the patch, including material design, patch structure and characterization. He has experience in the development of medical devices used in fetal surgery. He masters several manufacturing techniques involving biological tissue, biomaterials, bioadhesives, polymeric coatings and electrospinning.
PhD in Bioengineering specialized on Applied Science in Biomedicine. Germán focuses on the development of the patch, including material design, patch structure and characterization. He has experience in the development of medical devices used in fetal surgery. He masters several manufacturing techniques involving biological tissue, biomaterials, bioadhesives, polymeric coatings and electrospinning.
PhD in Bioengineering specialized on Applied Science in Biomedicine. Germán focuses on the development of the patch, including material design, patch structure and characterization. He has experience in the development of medical devices used in fetal surgery. He masters several manufacturing techniques involving biological tissue, biomaterials, bioadhesives, polymeric coatings and electrospinning.
PhD in Bioengineering specialized on Applied Science in Biomedicine. Germán focuses on the development of the patch, including material design, patch structure and characterization. He has experience in the development of medical devices used in fetal surgery. He masters several manufacturing techniques involving biological tissue, biomaterials, bioadhesives, polymeric coatings and electrospinning.
Juan Fusté
Market Access Specialist & Project Manager
Graduate in Biotechnology and MSc in Pharmaceutical Design and Engineering. Juan oversees the optimization of grants management, communications and Aortyx’ roadmap accomplishment. Besides, he is responsible of creating the market access strategy. He has previous experience in the field of cardiac and vascular regenerative medicine, at the Technical University of Denmark and at IQS.
Graduate in Biotechnology and MSc in Pharmaceutical Design and Engineering. Juan oversees the optimization of grants management, communications and Aortyx’ roadmap accomplishment. Besides, he is responsible of creating the market access strategy. He has previous experience in the field of cardiac and vascular regenerative medicine, at the Technical University of Denmark and at IQS.
Graduate in Biotechnology and MSc in Pharmaceutical Design and Engineering. Juan oversees the optimization of grants management, communications and Aortyx’ roadmap accomplishment. Besides, he is responsible of creating the market access strategy. He has previous experience in the field of cardiac and vascular regenerative medicine, at the Technical University of Denmark and at IQS.
Graduate in Biotechnology and MSc in Pharmaceutical Design and Engineering. Juan oversees the optimization of grants management, communications and Aortyx’ roadmap accomplishment. Besides, he is responsible of creating the market access strategy. He has previous experience in the field of cardiac and vascular regenerative medicine, at the Technical University of Denmark and at IQS.
Graduate in Biotechnology and MSc in Pharmaceutical Design and Engineering. Juan oversees the optimization of grants management, communications and Aortyx’ roadmap accomplishment. Besides, he is responsible of creating the market access strategy. He has previous experience in the field of cardiac and vascular regenerative medicine, at the Technical University of Denmark and at IQS.
Yvette Rabadà
R&D
PhD candidate in Bioengineering and MD. Yvette focuses on the development of new products to treat aortic aneurysms. She specialized in Pharmaceutical Chemistry at IQS and has previous experience in the field of drug development for cardiovascular diseases.
PhD in Chemical Engineering and specialized in Biomedical Engineering. He is the Head of Vascular Engineering and Applied Medicine and assistant professor at IQS School of Engineering. Jordi has been focused on vascular biology for more than ten years at MIT and IQS. He has collaborated with medical device companies to improve the design of coronary stents and arterial valves.
PhD candidate in Bioengineering and MD. Yvette focuses on the development of new products to treat aortic aneurysms. She specialized in Pharmaceutical Chemistry at IQS and has previous experience in the field of drug development for cardiovascular diseases.
Laura Mayenco
R&D
Graduate in Biomedical Engineering. Laura focuses on the development and validation of the intravascular deployment system of the patch. Besides, she helps in the design of the handle and a sealing system for the catheter.
PhD in Chemical Engineering and specialized in Biomedical Engineering. He is the Head of Vascular Engineering and Applied Medicine and assistant professor at IQS School of Engineering. Jordi has been focused on vascular biology for more than ten years at MIT and IQS. He has collaborated with medical device companies to improve the design of coronary stents and arterial valves.
Graduate in Biomedical Engineering. Laura focuses on the development and validation of the intravascular deployment system of the patch. Besides, she helps in the design of the handle and a sealing system for the catheter.
Francesc Canalejo
R&D
Graduate in Industrial Engineering Technologies and MSc student in Industrial Engineering and Industrial Business Management. Francesc is part of the R&D team and has been working on the development of a computational simulation model to support and validate the design of the intravascular deployment system of the patch. He also works on the manufacturing of prototypes for design testing.
Graduate in Industrial Engineering Technologies and MSc student in Industrial Engineering and Industrial Business Management. Francesc is part of the R&D team and has been working on the development of a computational simulation model to support and validate the design of the intravascular deployment system of the patch. He also works on the manufacturing of prototypes for design testing.
Graduate in Industrial Engineering Technologies and MSc student in Industrial Engineering and Industrial Business Management. Francesc is part of the R&D team and has been working on the development of a computational simulation model to support and validate the design of the intravascular deployment system of the patch. He also works on the manufacturing of prototypes for design testing.
Graduate in Industrial Engineering Technologies and MSc student in Industrial Engineering and Industrial Business Management. Francesc is part of the R&D team and has been working on the development of a computational simulation model to support and validate the design of the intravascular deployment system of the patch. He also works on the manufacturing of prototypes for design testing.
Graduate in Industrial Engineering Technologies and MSc student in Industrial Engineering and Industrial Business Management. Francesc is part of the R&D team and has been working on the development of a computational simulation model to support and validate the design of the intravascular deployment system of the patch. He also works on the manufacturing of prototypes for design testing.
Advisory Board
Elazer Edelman
Medical Advisor
MD and Phd. Elazer is the Director of the Institute for Medical Engineering and Science at MIT. He is Thomas D. and Virginia W. Cabot Professor at MIT and Professor of Medicine at Harvard Medical School. Dr. Edelman is also a senior physician in the Cardiac Care Unit at the Brigham and Women’s Hospital. He has more than thirty years of experience in vascular biology and devices invention and he is also a consultant for FDA and several medical devices.
MD and Phd. Elazer is the Director of the Institute for Medical Engineering and Science at MIT. He is Thomas D. and Virginia W. Cabot Professor at MIT and Professor of Medicine at Harvard Medical School. Dr. Edelman is also a senior physician in the Cardiac Care Unit at the Brigham and Women’s Hospital. He has more than thirty years of experience in vascular biology and devices invention and he is also a consultant for FDA and several medical devices.
MD and Phd. Elazer is the Director of the Institute for Medical Engineering and Science at MIT. He is Thomas D. and Virginia W. Cabot Professor at MIT and Professor of Medicine at Harvard Medical School. Dr. Edelman is also a senior physician in the Cardiac Care Unit at the Brigham and Women’s Hospital. He has more than thirty years of experience in vascular biology and devices invention and he is also a consultant for FDA and several medical devices.
Rosendo Garganta
Business Advisor
MBA. Rosendo is the CEO of Devicare, a technology-based company dedicated to develop digital therapeutics solutions. He is also a Clinical and Biomedical Entrepreneur and he collaborates with different Barcelona based Universities as a Visiting Associate Professor in Entrepreneurship.
MBA. Rosendo is the CEO of Devicare, a technology-based company dedicated to develop digital therapeutics solutions. He is also a Clinical and Biomedical Entrepreneur and he collaborates with different Barcelona based Universities as a Visiting Associate Professor in Entrepreneurship.
MBA. Rosendo is the CEO of Devicare, a technology-based company dedicated to develop digital therapeutics solutions. He is also a Clinical and Biomedical Entrepreneur and he collaborates with different Barcelona based Universities as a Visiting Associate Professor in Entrepreneurship.
MBA. Rosendo is the CEO of Devicare, a technology-based company dedicated to develop digital therapeutics solutions. He is also a Clinical and Biomedical Entrepreneur and he collaborates with different Barcelona based Universities as a Visiting Associate Professor in Entrepreneurship.
Mercedes Balcells
Scientific Advisor
PhD in Macromolecular Chemistry. She is a Principal Research Scientist at IMES (MIT) and a full professor at IQS. She has more than fifteen years of experience in vascular biology and biomaterials. In 2010 she founded Regenear, a company focused on developing biokits to regenerate tridimensional facial cartilage from patient’s own cells.
PhD in Macromolecular Chemistry. She is a Principal Research Scientist at IMES (MIT) and a full professor at IQS. She has more than fifteen years of experience in vascular biology and biomaterials. In 2010 she founded Regenear, a company focused on developing biokits to regenerate tridimensional facial cartilage from patient’s own cells.
PhD in Macromolecular Chemistry. She is a Principal Research Scientist at IMES (MIT) and a full professor at IQS. She has more than fifteen years of experience in vascular biology and biomaterials. In 2010 she founded Regenear, a company focused on developing biokits to regenerate tridimensional facial cartilage from patient’s own cells.
Adam Groothuis
Business Advisor
MBA. Adam is the founder of two technological startups and the Vice-President of Mitralign. He has more than twenty years of experience optimizing medical devices for cardiovascular diseases. He is also advisor for several medical device companies.
MBA. Adam is the founder of two technological startups and the Vice-President of Mitralign. He has more than twenty years of experience optimizing medical devices for cardiovascular diseases. He is also advisor for several medical device companies.
MBA. Adam is the founder of two technological startups and the Vice-President of Mitralign. He has more than twenty years of experience optimizing medical devices for cardiovascular diseases. He is also advisor for several medical device companies.
MBA. Adam is the founder of two technological startups and the Vice-President of Mitralign. He has more than twenty years of experience optimizing medical devices for cardiovascular diseases. He is also advisor for several medical device companies.
Frederic Llordarcs
Business Advisor
MD and MBA. Frederic is Co-founder and Global Business Development Manager at Doctoralia. He has extensive experience in healthcare management, healthcare marketing and healthcare insurances. Currently, he is focused on helping emerging digital projects to grow.
MD and MBA. Frederic is Co-founder and Global Business Development Manager at Doctoralia. He has extensive experience in healthcare management, healthcare marketing and healthcare insurances. Currently, he is focused on helping emerging digital projects to grow.
MD and MBA. Frederic is Co-founder and Global Business Development Manager at Doctoralia. He has extensive experience in healthcare management, healthcare marketing and healthcare insurances. Currently, he is focused on helping emerging digital projects to grow.
MD and MBA. Frederic is Co-founder and Global Business Development Manager at Doctoralia. He has extensive experience in healthcare management, healthcare marketing and healthcare insurances. Currently, he is focused on helping emerging digital projects to grow.
MD and MBA. Frederic is Co-founder and Global Business Development Manager at Doctoralia. He has extensive experience in healthcare management, healthcare marketing and healthcare insurances. Currently, he is focused on helping emerging digital projects to grow.
The ultimate solution for aortic diseases
The ultimate solution for aortic diseases
The ultimate solution for aortic diseases
© 2019. AORTYX.